Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
Oramed Pharmaceuticals: 'Hold' On Oral Insulin Drug Failure Pivot And New Strategic Investment Direction
Reviewing Oramed Pharmaceuticals (NASDAQ:ORMP) & Akanda (NASDAQ:AKAN)
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
Head to Head Review: GN Store Nord (OTCMKTS:GNNDY) and Oramed Pharmaceuticals (NASDAQ:ORMP)
Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Passes Above 50 Day Moving Average – Here’s Why
Comparing QuidelOrtho (NASDAQ:QDEL) & Oramed Pharmaceuticals (NASDAQ:ORMP)
Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Above Fifty Day Moving Average – Time to Sell?
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
Oramed and Lifeward Announce Strategic Transaction
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
Reviewing Oramed Pharmaceuticals (NASDAQ:ORMP) & GE HealthCare Technologies (NASDAQ:GEHC)
Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback
Oramed Reports Fiscal Third Quarter 2025 Financial Results
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
Oramed Pharmaceuticals Issues Letter to Shareholders
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
3 Micro-Cap Moonshots for Fearless Investors
Oramed Letter to Shareholders
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally
Best Penny Stocks To Buy Today? 4 To Watch Under $5
Why Oramed Pharmaceuticals Stock Is Crashing Today
Why Is Oramed (ORMP) Stock Down 75% Today?
Oramed's oral insulin pill fails; stock is down 72%
Oramed: NASH Biotech Play With Added Bonus
Oramed: Oral Insulin For Type 2 Diabetes May Become A Reality
Why Oramed Pharmaceuticals Stock Is On Fire Today
Why Oramed Pharmaceuticals Stock Rocketed Higher Today
Oramed And Oral Insulin: Can This Small Company Really Do It?
MyMD Pharmaceuticals Investment Company Oravax Medical Signs Cooperation and Purchase Agreement for Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccine to be Commercialized in Southeast Asia
Oramed's Oravax sub signs pre-purchase agreement for 10 million oral COVID-19 vaccines with Tan Thanh
MyMD Pharmaceuticals Investment Company Oravax Medical and Genomma Lab Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America
Oramed: Prospects Still Remain Despite Merck-Ridgeback's Progress
7 Top-Rated Pharmaceutical Stocks To Invest in for October
MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine
Oramed to Present at Canaccord Genuity's 41st Annual Growth Conference
Oramed Will Soon Start Clinical Trials For Oral COVID-19 Vaccine In Israel, Out licensed Injectable Version To Premas Biotech In India
Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
Oramed Issues Letter to Shareholders with Updates on Oral Insulin and COVID-19 Vaccine
Oramed Pharmaceuticals: Interesting Late-Stage Oral Insulin Developer
Oramed Pharmaceuticals and Oravax Medical to be Featured in Alliance Global Partners' Grand Rounds: A Webinar in Biotech and Specialty Pharma
Oramed Initiates Second Phase 3 Oral Insulin Study Under the FDA's Approved Dual Concurrent Protocol
ORMP Stock Price Increased Over 40% Pre-Market: Why It Happened
Premas Biotech and Oramed Announce Oral COVID-19 Vaccine Candidate That Produces Antibodies After a Single Dose